Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > TROLL is TOAST ! !

<< Previous

Bullboard Posts

Next >>

Comment by Moonshiner592on May 27, 2020 12:47am

132 Views

Post# 31076440

RE:RE:TROLL is TOAST ! !

MiSdyngNASTY wrote: Nah bra. If PENNY was legit shortselling he just won big. He never has to pay back anyone because the shares are considered worthless on a delist. The broker cancels his short seller debt and returns all collateral. Not sure if that applies to this Grey market situation but if so and if Penny was shorting, he or she is a complete and utter GENIUS. I'm in awe.

..... said sockpuppet MiSdyngNASTY ... sipping wine and high on mushrooms,...

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (June 28, 2024)